1. Home
  2. ELBM vs ELUT Comparison

ELBM vs ELUT Comparison

Compare ELBM & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electra Battery Materials Corporation

ELBM

Electra Battery Materials Corporation

HOLD

Current Price

$0.57

Market Cap

58.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.06

Market Cap

46.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELBM
ELUT
Founded
2011
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
46.5M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ELBM
ELUT
Price
$0.57
$1.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.15
$6.00
AVG Volume (30 Days)
770.8K
164.8K
Earning Date
05-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
0.87
Revenue
N/A
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
N/A
$1.29
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.50
52 Week High
$8.70
$2.99

Technical Indicators

Market Signals
Indicator
ELBM
ELUT
Relative Strength Index (RSI) 31.47 48.56
Support Level N/A $0.86
Resistance Level $1.29 $1.15
Average True Range (ATR) 0.04 0.10
MACD -0.00 -0.01
Stochastic Oscillator 16.44 23.08

Price Performance

Historical Comparison
ELBM
ELUT

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: